Writer

● Recently verified Last updated: Apr 26, 2026 Data last verified: May 22, 2026

Writer: $1.9B valuation, IPO Readiness 74, Series D. Full-stack enterprise AI platform for deploying AI applications across entire organizations. Track live on The IPO Stack.

Series DArtificial Intelligencepre-ipo
74
/100
IPO Readiness Score
Grade B — Moderate IPO Readiness
TechStackIPO proprietary score based on funding scale, valuation, stage progression & momentum.
Track Writer →

Full-stack enterprise AI platform for deploying AI applications across entire organizations.

Valuation
$1.9B
Total Funding
$676M
Stage
Series D
Sector
Artificial Intelligence
Headquarters
San Francisco, CA
CEO
May Habib
IPO Status
pre-ipo

Funding History

Round Amount Date Lead Investors
Series B $200M Sep 2024 Premji Invest, Salesforce Ventures
Series A $100M Jan 2023 ICONIQ Growth
Seed $21M Sep 2021 Emergence Capital
The IPO Stack Newsletter

Get Tuesday's IPO moves + one deep-dive in your inbox

Scores, valuations, and IPO signals for the companies that matter. 5-minute read, every Tuesday.

🚀

2026 IPO Watchlist

Top companies most likely to IPO in 2026, ranked by IPO Readiness Score.

SpaceX
$275B · Aerospace & Defense
99
Readiness
OpenAI
$852B · Artificial Intelligence
89
Readiness
Canva
$42B · Design & Creative
88
Readiness
Replit
$12B · Artificial Intelligence
86
Readiness
Stripe
$159B · Fintech
86
Readiness
Anthropic
$380B · Artificial Intelligence
85
Readiness
Scale AI
$14B · Artificial Intelligence
85
Readiness
Plaid
$13.4B · Fintech
84
Readiness

Related Analysis

📊 IPO Readiness Stack 🏭 Artificial Intelligence Sector ⚖️ vs SpaceX ⚖️ vs OpenAI 📈 IPO Pipeline

Track Writer IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO — the pre-IPO intelligence platform.

Frequently Asked Questions

When is Writer going public? +

Writer has not announced a specific IPO date as of 2026. With an IPO Readiness Score of 74/100, the company shows strong pre-IPO signals. Subscribe to The IPO Stack newsletter for weekly updates.

What is Writer's current valuation? +

Writer is valued at $1.9B as of September 2024. This valuation is based on its most recent private funding round tracked by TechStackIPO.

How can I invest in Writer before IPO? +

Accredited investors can access Writer shares through secondary market platforms, pre-IPO investment funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace tracks available access options. Note: pre-IPO investments carry higher risk and limited liquidity compared to public market investing.

What is Writer's IPO Readiness Score? +

Writer scores 74/100 (Grade: B) on TechStackIPO's IPO Readiness Index. The score evaluates funding scale, valuation trajectory, funding momentum, stage progression, and company maturity. Scores above 70 indicate strong near-term IPO potential.

How much total funding has Writer raised? +

Writer has raised $676M in total venture capital and private equity funding, with backing from Premji Invest, Salesforce Ventures, ICONIQ Growth.

Who are Writer's key investors? +

Writer's notable investors include Premji Invest, Salesforce Ventures, ICONIQ Growth, Emergence Capital. Full investor details, funding round history, and lead investor breakdowns are available on TechStackIPO.

What sector is Writer in? +

Writer is a Artificial Intelligence company. Full-stack enterprise AI platform for deploying AI applications across entire organizations.

📡 IPO Intelligence
$49/mo — Unlimited Reports + Real-Time Updates
Unlimited company analysis reports — all 375+ companies
Real-time IPO alerts — know the moment S-1s are filed
Verified data updated daily — not chatbot hallucinations
💡 Tracking multiple companies? Full access pays for itself after 3 reports.
$49
per month
Subscribe Now →
Cancel anytime · Secure via Stripe
Institutional Research
$19 — Get the Complete Writer Analysis Brief
Executive summary & IPO readiness breakdown
Competitive positioning & funding trajectory
Bull / bear thesis with pricing projections
S-1 timeline estimate & risk assessment
$19
One-time
Don't find it useful? Refund within 7 days.
Secure checkout · Stripe · 24h delivery